These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32951237)

  • 1. Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy.
    Malpetti M; Passamonti L; Rittman T; Jones PS; Vázquez Rodríguez P; Bevan-Jones WR; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Ann Neurol; 2020 Dec; 88(6):1194-1204. PubMed ID: 32951237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation predicts disease progression in progressive supranuclear palsy.
    Malpetti M; Passamonti L; Jones PS; Street D; Rittman T; Fryer TD; Hong YT; Vàsquez Rodriguez P; Bevan-Jones WR; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):769-775. PubMed ID: 33731439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcortical
    Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Whitwell JL; Lowe VJ; Tosakulwong N; Weigand SD; Senjem ML; Schwarz CG; Spychalla AJ; Petersen RC; Jack CR; Josephs KA
    Mov Disord; 2017 Jan; 32(1):124-133. PubMed ID: 27787958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Holland N; Malpetti M; Rittman T; Mak EE; Passamonti L; Kaalund SS; Hezemans FH; Jones PS; Savulich G; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2022 Mar; 145(1):340-348. PubMed ID: 34398211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.
    Whitwell JL; Tosakulwong N; Schwarz CG; Botha H; Senjem ML; Spychalla AJ; Ahlskog JE; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Mov Disord; 2019 Jan; 34(1):105-113. PubMed ID: 30468693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study.
    Cheong I; Du Y; Smith G; Hua J; Li X; Pantelyat A
    Neurodegener Dis; 2023; 23(3-4):35-42. PubMed ID: 38527450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased basal ganglia binding of
    Smith R; Schain M; Nilsson C; Strandberg O; Olsson T; Hägerström D; Jögi J; Borroni E; Schöll M; Honer M; Hansson O
    Mov Disord; 2017 Jan; 32(1):108-114. PubMed ID: 27709757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
    Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T
    Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Schonhaut DR; McMillan CT; Spina S; Dickerson BC; Siderowf A; Devous MD; Tsai R; Winer J; Russell DS; Litvan I; Roberson ED; Seeley WW; Grinberg LT; Kramer JH; Miller BL; Pressman P; Nasrallah I; Baker SL; Gomperts SN; Johnson KA; Grossman M; Jagust WJ; Boxer AL; Rabinovici GD
    Ann Neurol; 2017 Oct; 82(4):622-634. PubMed ID: 28980714
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Nicastro N; Rodriguez PV; Malpetti M; Bevan-Jones WR; Simon Jones P; Passamonti L; Aigbirhio FI; O'Brien JT; Rowe JB
    J Neurol; 2020 Feb; 267(2):341-349. PubMed ID: 31641878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
    Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
    Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liu FT; Lu JY; Li XY; Liang XN; Jiao FY; Ge JJ; Wu P; Li G; Shen B; Wu B; Sun YM; Zhu YH; Luo JF; Yen TC; Wu JJ; Zuo CT; Wang J;
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1395-1405. PubMed ID: 36627498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.
    Coakeley S; Cho SS; Koshimori Y; Rusjan P; Harris M; Ghadery C; Kim J; Lang AE; Wilson A; Houle S; Strafella AP
    J Cereb Blood Flow Metab; 2017 Sep; 37(9):3150-3160. PubMed ID: 28155586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum.
    Bevan-Jones WR; Cope TE; Jones PS; Kaalund SS; Passamonti L; Allinson K; Green O; Hong YT; Fryer TD; Arnold R; Coles JP; Aigbirhio FI; Larner AJ; Patterson K; O'Brien JT; Rowe JB
    Brain; 2020 Mar; 143(3):1010-1026. PubMed ID: 32179883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Passamonti L; Rodríguez PV; Hong YT; Allinson KSJ; Bevan-Jones WR; Williamson D; Jones PS; Arnold R; Borchert RJ; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Neurology; 2018 May; 90(22):e1989-e1996. PubMed ID: 29703774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity.
    Kaalund SS; Passamonti L; Allinson KSJ; Murley AG; Robbins TW; Spillantini MG; Rowe JB
    Acta Neuropathol Commun; 2020 Feb; 8(1):11. PubMed ID: 32019605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.